A new paper from the University of Leeds is raising awareness of an unusual Long Covid condition known as ‘blue legs’ symptom
An unusual case of a Long Covid patient’s legs turning blue after ten minutes of standing highlights the need for greater awareness of this symptom among people with the condition, according to new research.
The paper, authored by Dr Manoj Sivan at the University of Leeds, focuses on the case of one 33-year man who developed with acrocyanosis – venous pooling of blood in the legs.
A minute after standing, the patient’s legs began to redden and became increasingly blue over time, with veins becoming more prominent.
After ten minutes the colour was much more pronounced, with the patient describing a heavy, itchy sensation in his legs.
His original colour returned two minutes after he returned to a non-standing position.
The patient said he had started to experience the discolouration since his Covid-19 infection.
He was diagnosed with postural orthostatic tachycardia syndrome (POTS), a condition that causes an abnormal increase in heart rate on standing.
Dr Sivan, Associate Clinical Professor and Honorary Consultant in Rehabilitation Medicine in the University of Leeds’ School of Medicine, said: “This was a striking case of acrocyanosis in a patient who had not experienced it before his Covid-19 infection.
“Patients experiencing this may not be aware that it can be a symptom of Long Covid and dysautonomia and may feel concerned about what they are seeing.
“Similarly, clinicians may not be aware of the link between acrocyanosis and Long Covid.
“We need to ensure that there is more awareness of dysautonomia in Long Covid so that clinicians have the tools they need to manage patients appropriately.”
Long Covid affects multiple systems in the body and has an array of symptoms, affecting patients’ ability to perform daily activities.
The condition also affects the autonomic nervous system, which is responsible for regulating blood pressure and heart rate.
Acrocyanosis has previously been observed in children with dysfunction of the autonomic nervous system (dysautonomia), a common symptom of post-viral syndromes.
Previous research by Sivan’s team has shown that both dysautonomia and POTS frequently develop in people with Long Covid.
Dysautonomia is also seen in a number of other long-term conditions such as fibromyalgia and myalgic encephalomyelitis, also known as chronic fatigue syndrome or ME.
Sivan said: “We need more awareness about dysautonomia in long-term conditions; more effective assessment and management approaches, and further research into the syndrome.
“This will enable both patients and clinicians to better manage these conditions.”
The research is the latest work by the team in the field of autonomic medicine.
Other developments include a home test for people with symptoms of autonomic dysfunction in conditions such as Long Covid, chronic fatigue syndrome, fibromyalgia, and diabetes 1 and 2, where people experience dizziness or blackouts.
The research is published in the Lancet.